Foslevodopa

ATC N04BA07 · 5 markets · 7 records

Foslevodopa 5 markets · 7 records Forms

AU 3 records · 3 strengths

2,400 mg/10 mLinjectionVyalev also in GB
2,400 mginjectionVYALEV foslevodopa 2400 mg/10 mL and foscarbidopa 120 mg/10 mL solution for subcutaneous infusion vial unknown

Records without a stated strength · 1 Vyalev

US 1 records · 1 strengths

240 mginjectionVyalev

GB 1 records · 1 strengths

2,400 mg/10 mLinjectionProduodopa 2.4g/10ml / 120mg/10ml solution for infusion vials also in AU

CA 1 records · 1 strengths

240 mgliquidVyalev

ES 1 records · 1 strengths

240 mg/1 mLinjectionDUODOPA

The same ingredient can carry completely different brand names in different countries, and the same name can point to a different ingredient. Listed by country — not interchangeable.

Discontinued, withdrawn or unverified-status products are hidden by default; Hong Kong and Australia records are shown as exceptions.

A side-by-side table is offered only when this ingredient has records in many markets; otherwise this list is the whole picture.